The federal agency continues to offer advice for healthcare and pharma industry professionals, and to take action against companies acting out of bounds.
The purchase of the Irish pharmacovigilance specialist is intended to expand’s Diamond’s European presence, and increase its senior-level industry expertise.
The company’s global analysis from thousands of studies and sites indicates dramatic shifts in enrollment across several countries since the pandemic began.
